Novo Nordisk debuts Wegovy weight-loss pill in the U.S.

CBS news | 15:10 05-01-2026 | Finance

FDA-approved semaglutide drug is the first GLP-1 pill for weight loss available in the U.S., according to drugmaker Novo Nordisk.

© 2026 Americas Inside. All rights reserved.
About Us Privacy Terms of Use Disclaimer Cookie Policy Contact